Enzo Biochem, Inc., a biosciences and diagnostics company, and CLX Health, developer of cloud-based solutions to manage the COVID-19 testing ecosystem through its TrustAssure Global Network, have announced a new collaboration to provide rapid access in New York and New Jersey to COVID-19 PCR testing that will be required for international travel from the U.S. to destinations around the world.
Using this online service, travelers will be able to schedule PCR tests immediately and receive results in advance of travel by using CLX Health’s TrustAssure Global Testing Platform, which includes COVID-19 testing partners in more than 81 countries.
“The TrustAssure platform offers consumers access to the latest testing location data around the world. We have a directory of 15,000 plus verified COVID-19 testing sites worldwide and are excited to be adding Enzo’s testing sites in New York and New Jersey to help meet demand for testing in this important region as travel increases in the coming months,” says Bob Fluery, Global Lab Director for CLX Health. “We are committed to working with our partners to provide customers with easy solutions to meet testing requirements and ensure a safe travel experience.”
The seamless process enables travelers to find and book tests at the most convenient location with a trusted health provider — including physician-authorized testing at locations throughout the metropolitan New York/New Jersey area — and then transmit compliance status to their travel provider. Many global airlines are already using TrustAssure Global Testing Platform to offer their customers an easy-to-use option to meet the testing requirements for international travelers. These travelers will have access to their test results through the Enzo Patient Portal.
“As international travel rapidly opens up, demand for PCR testing has shifted from surveillance testing for schools and institutions to testing for discretionary activities including travel and entertainment. Travelers can instantly schedule a PCR test at Enzo’s patient service center locations throughout New York and New Jersey. The PCR test is processed using Enzo’s proprietary GENFLEX platform at our NY State CLIA certified lab,” says Elazar Rabbani, PhD, CEO of Enzo. “The mobile experience handles the necessary physician authorizations and delivers results directly to the customer. We anticipate that proof of testing will be a requirement for travel for at least several more months in the effort to keep millions of international travelers safe. The application provides travelers easy access to results that will confirm their negative status to airline representatives.”
In this strategic partnership, Enzo’s test processing locations across New York and New Jersey will be added to TrustAssure’s network of COVID-19 testing providers across the country. Customers will be notified of their results through the secure online portal. If a negative COVID-19 result is processed, a TrustAssure ReadyToFly message will be generated as proof of health status and sent to the airline partner.
“While the Centers for Disease Control and Prevention recently updated guidance regarding mask and social distancing mandates for the vaccinated, the rules for face coverings and PCR testing remain in place for international travel,” says Barry Weiner, president of Enzo Biochem. “As more travelers book vacations out of the country, we are pleased to be a convenient resource they can depend on for easy and rapid access to COVID-19 testing to ensure safe travel.”